VANGUARD VARIABLE INSURANCE FUND
NSAR-A, EX-27, 2000-05-30
Previous: VANGUARD VARIABLE INSURANCE FUND, NSAR-A, EX-27, 2000-05-30
Next: AVANIR PHARMACEUTICALS, S-8, 2000-05-30



<TABLE> <S> <C>

<ARTICLE> 6
<RESTATED>
<CIK> 0000857490
<NAME> VANGUARD VARIABLE INSURANCE FUND
<SERIES>
   <NUMBER> 09
   <NAME> SMALL COMPANY GROWTH PORTFOLIO
<MULTIPLIER> 1000
<CURRENCY> US

<S>                             <C>
<PERIOD-TYPE>                   6-MOS
<FISCAL-YEAR-END>                          SEP-30-2000
<PERIOD-START>                             OCT-01-1999
<PERIOD-END>                               MAR-31-2000
<EXCHANGE-RATE>                                      1
<INVESTMENTS-AT-COST>                           386121
<INVESTMENTS-AT-VALUE>                          455445
<RECEIVABLES>                                    10354
<ASSETS-OTHER>                                      94
<OTHER-ITEMS-ASSETS>                                 0
<TOTAL-ASSETS>                                  465893
<PAYABLE-FOR-SECURITIES>                          4904
<SENIOR-LONG-TERM-DEBT>                              0
<OTHER-ITEMS-LIABILITIES>                        17334
<TOTAL-LIABILITIES>                              22238
<SENIOR-EQUITY>                                      0
<PAID-IN-CAPITAL-COMMON>                        281823
<SHARES-COMMON-STOCK>                            20285
<SHARES-COMMON-PRIOR>                            13015
<ACCUMULATED-NII-CURRENT>                         1113
<OVERDISTRIBUTION-NII>                               0
<ACCUMULATED-NET-GAINS>                          91395
<OVERDISTRIBUTION-GAINS>                             0
<ACCUM-APPREC-OR-DEPREC>                         69324
<NET-ASSETS>                                    443655
<DIVIDEND-INCOME>                                  791
<INTEREST-INCOME>                                 1101
<OTHER-INCOME>                                     113
<EXPENSES-NET>                                     736
<NET-INVESTMENT-INCOME>                           1269
<REALIZED-GAINS-CURRENT>                         92271
<APPREC-INCREASE-CURRENT>                        38627
<NET-CHANGE-FROM-OPS>                           132167
<EQUALIZATION>                                       0
<DISTRIBUTIONS-OF-INCOME>                          928
<DISTRIBUTIONS-OF-GAINS>                             0
<DISTRIBUTIONS-OTHER>                                0
<NUMBER-OF-SHARES-SOLD>                          11565
<NUMBER-OF-SHARES-REDEEMED>                       4363
<SHARES-REINVESTED>                                 68
<NET-CHANGE-IN-ASSETS>                          276128
<ACCUMULATED-NII-PRIOR>                            772
<ACCUMULATED-GAINS-PRIOR>                        (876)
<OVERDISTRIB-NII-PRIOR>                              0
<OVERDIST-NET-GAINS-PRIOR>                           0
<GROSS-ADVISORY-FEES>                              296
<INTEREST-EXPENSE>                                   0
<GROSS-EXPENSE>                                    736
<AVERAGE-NET-ASSETS>                            297761
<PER-SHARE-NAV-BEGIN>                            12.87
<PER-SHARE-NII>                                   0.06
<PER-SHARE-GAIN-APPREC>                           9.01
<PER-SHARE-DIVIDEND>                              0.07
<PER-SHARE-DISTRIBUTIONS>                            0
<RETURNS-OF-CAPITAL>                                 0
<PER-SHARE-NAV-END>                              21.87
<EXPENSE-RATIO>                                   0.49


</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission